1
|
Gumenyuk LN, Sherengovskaya YV, Gorlova NA, Prokhorov DV, Basnaev UI, Karakursakov NE. [Comparison of balneotherapy and balneotherapy combined with magnetic-laser therapy at a sanatorium-resort stage of treatment of patients with eczema]. VOPROSY KURORTOLOGII, FIZIOTERAPII, I LECHEBNOI FIZICHESKOI KULTURY 2023; 100:28-38. [PMID: 37735793 DOI: 10.17116/kurort202310004128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/23/2023]
Abstract
The search for new rational ways to improve the effectiveness of treatment and rehabilitation measures of patients with true eczema continues to be one of the pressing issues in modern clinical dermatology. OBJECTIVE The comparative analysis of influence of different variants of SCL: balneotherapy and balneotherapy combined with magnetic laser therapy on the dermatological status, IL-4 and IL-13 level, psycho-emotional state and QOL evaluation in patients with true eczema. MATERIAL AND METHODS The study involved 112 patients with true eczema undergoing spa treatment (SCR) (54 in the balneotherapy group and 58 in the balneotherapy group combined with magnetic laser therapy. The effectiveness of SCR was assessed using the EASI, HARS and MADRS scales, and the DLQI questionnaire. The dynamics of IL-4 and IL-13 plasma levels were studied. The duration of the study was 6 months and 14 days. RESULTS After 14 days of SCR, a statistically significant reduction of the EASI index was more pronounced in the balneotherapy group in combination with MLT compared to the balneotherapy group (p=0.041). Balneotherapy combined with MLT contributed to a statistically significant reduction in the HARS and HDRS scores. The decrease in IL-4 and IL-13 levels was statistically more significant in the balneotherapy group in combination with MLT. The combined use of balneotherapy and MLT in comparison with the balneotherapy group was accompanied by a more pronounced improvement in QOL. The combined use of balneotherapy and MLT in the follow-up phase showed a long-term positive effect: 6 months after completing SCR, the number of patients who had clinical remission was statistically significantly higher than that of the balneotherapy group (87.4% vs 22.5%). CONCLUSION The combined use of balneotherapy and MLT compared with balneotherapy in patients with true eczema on SCR was shown to be advantageous. The complex application of balneotherapy and MLT decreases inflammatory biomarker scores, improves dermatological and psychoemotional status, QOL parameters and is well tolerated.
Collapse
Affiliation(s)
- L N Gumenyuk
- Medical Academy named after S.I. Georgievsky Academic Unit of V.I. Vernadsky Crimean Federal University, Simferopol, Russia
| | - Yu V Sherengovskaya
- Medical Academy named after S.I. Georgievsky Academic Unit of V.I. Vernadsky Crimean Federal University, Simferopol, Russia
| | - N A Gorlova
- Medical Academy named after S.I. Georgievsky Academic Unit of V.I. Vernadsky Crimean Federal University, Simferopol, Russia
| | - D V Prokhorov
- Medical Academy named after S.I. Georgievsky Academic Unit of V.I. Vernadsky Crimean Federal University, Simferopol, Russia
| | - U I Basnaev
- Medical Academy named after S.I. Georgievsky Academic Unit of V.I. Vernadsky Crimean Federal University, Simferopol, Russia
| | - N E Karakursakov
- Medical Academy named after S.I. Georgievsky Academic Unit of V.I. Vernadsky Crimean Federal University, Simferopol, Russia
| |
Collapse
|
2
|
Khatoon F, Azahar M, Jabeen A, Uddin Q, Husain N, Naikodi MAR. Treatment of chronic plaque psoriasis with herbal Unani formulations: A randomized control trial of efficacy and safety. JOURNAL OF ETHNOPHARMACOLOGY 2022; 296:115456. [PMID: 35724745 DOI: 10.1016/j.jep.2022.115456] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Revised: 05/13/2022] [Accepted: 06/09/2022] [Indexed: 06/15/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Psoriasis, despite modern therapeutic options, is incurable and recurrent. In Unani (Greco-Arab) medicine, many medications and formulations have been prescribed by eminent scholars for conditions clinically similar to psoriasis, though empirical evidence is sparse. Hence, the experimental formulations ItrīfalShāhtra and MarhamḤina were chosen to be compared to the standard therapies PUVAsol and petrolatum for their safety and efficacy. MATERIALS AND METHODS This open-label, randomized control clinical trial was conducted on 66 male and female participants with chronic plaque psoriasis, ranging in age from 18 to 65 years. In each group, 33 participants were block randomized to either receive Unani formulations or control drugs for 12 weeks. The Unani group received oral Itrīfal Shāhtra (a semisolid paste) and topical MarhamḤina (an ointment) twice daily, and the control group received oral 8-methoxypsoralen and topical petroleum jelly for local application. Participants of both groups were advised to get daily sunlight exposure for 5-15 min. The primary outcome measure was the change in psoriasis area and severity index (PASI) assessed at each visit. Secondary outcome measures were patient global assessment on a 100 mm VAS applied at baseline and after 12 weeks of treatment and change in subjective parameters including erythema, induration, scaling, and itching, assessed on a 5-point scale at every visit. Hemogram, LFTs, RFTs, CXR, ECG, urine, and stool tests were all assessed at baseline and after treatment for the safety of the drugs. RESULTS The per-protocol analysis was done on 25 participants in each group. The mean ± SD of the psoriasis area severity index (PASI) significantly decreased from 27.88 ± 12.01 and 23.61 ± 9.79 at baseline to 5.01 ± 4.59 and 9.85 ± 7.16 after completion of the trial therapies in both Unani and control groups, respectively. Also, the test formulations outperformed the control drugs on clinically significant endpoints, PASI 50 and PASI 75, with all 25 participants achieving PASI 50 and 76% achieving PASI 75. CONCLUSION The trial formulations, ItrīfalShāhtra and MarhamḤina may be superior to control drugs PUVAsol and petrolatum in terms of safety, efficacy, and tolerability in the treatment of chronic plaque psoriasis. Thus, the Unani formulations may further be evaluated in a well-designed multicentric superiority trial with an adequate sample size.
Collapse
Affiliation(s)
- Faiza Khatoon
- Department of Medicine (Moalajat), National Research Institute of Unani Medicine, for Skin Disorders (NRIUMSD), Hyderabad, 500038, India.
| | - Mohd Azahar
- Department of Medicine (Moalajat), Rajasthan Unani Medical College and Hospital, Jaipur, Rajasthan, 302004, India.
| | - Arzeena Jabeen
- Department of Medicine (Moalajat), National Research Institute of Unani Medicine, for Skin Disorders (NRIUMSD), Hyderabad, 500038, India.
| | - Qamar Uddin
- Department of Medicine (Moalajat), National Research Institute of Unani Medicine, for Skin Disorders (NRIUMSD), Hyderabad, 500038, India.
| | - Nazim Husain
- Department of Medicine (Moalajat), Luqman Unani Medical College Hospital and Research Center, Bijapur, Karnataka, 586101, India.
| | - Mohammed Abdul Rasheed Naikodi
- Drug Standardization Unit, National Research Institute of Unani Medicine, for Skin Disorders (NRIUMSD), Hyderabad, 500038, India.
| |
Collapse
|
3
|
Mai ZM, Byrne SN, Little MP, Sargen MR, Cahoon EK. Solar UVR and Variations in Systemic Immune and Inflammation Markers. JID INNOVATIONS 2021; 1:100055. [PMID: 34909751 PMCID: PMC8659735 DOI: 10.1016/j.xjidi.2021.100055] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2021] [Revised: 06/23/2021] [Accepted: 06/28/2021] [Indexed: 11/23/2022] Open
Abstract
The characterization of the effects of solar UVR on a broad set of circulating markers in systemic immunity and inflammation may provide insight into the mechanisms responsible for the UVR associations observed for several benign and malignant diseases. We examined the associations between exposure to solar UVR and circulating levels of 78 markers among 1,819 individuals aged 55–74 years who participated in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial using multiplex assays. Solar UVR was derived by linking the geocoded locations of 10 screening centers across the continental United States and the date of blood draw to the National Solar Radiation Database from 1993 to 2005. We assessed associations between ambient solar UVR and dichotomized marker levels using adjusted weighted logistic regression models and applied a 5% false discovery rate criterion to P-values. UVR exposure was associated (P < 0.05) with 9 of the 78 markers. CCL27, CCL4, FGF2, GM-CSF, IFN-γ, soluble IL4R, IL-7, and IL-11 levels were lower with increasing UVR tertile, with adjusted ORs ranging from 0.66 to 0.80, and the significant association for CCL27 withstood multiple comparison correction. In contrast, CRP levels were elevated with increasing UVR. Solar UVR was associated with alterations in systemic immune and inflammation marker levels.
Collapse
Affiliation(s)
- Zhi-Ming Mai
- Radiation Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland, USA
| | - Scott N Byrne
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.,Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Westmead, Australia
| | - Mark P Little
- Radiation Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland, USA
| | - Michael R Sargen
- Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland, USA
| | - Elizabeth K Cahoon
- Radiation Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland, USA
| |
Collapse
|
4
|
Sharma K, Choudhary S, Silakari O. Portraying molecular modulation and therapeutic aspects of psoriasis: Retrospection and current status. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.130770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
5
|
Chen W, Wang W, Yong L, Zhen Q, Yu Y, Ge H, Mao Y, Cao L, Zhang R, Hu X, Li Z, Wang Y, Fan W, Xu Q, Zhang H, Chen S, Wu J, Sun L. Genome-wide meta-analysis identifies ten new psoriasis susceptibility loci in the Chinese population. J Genet Genomics 2021; 49:177-180. [PMID: 34695602 DOI: 10.1016/j.jgg.2021.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2021] [Revised: 10/04/2021] [Accepted: 10/06/2021] [Indexed: 11/15/2022]
Affiliation(s)
- Weiwei Chen
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Wenjun Wang
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Liang Yong
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Qi Zhen
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Yafen Yu
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Huiyao Ge
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Yiwen Mao
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Lu Cao
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Ruixue Zhang
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Xia Hu
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Zhuo Li
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Yirui Wang
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Wencheng Fan
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Qiongqiong Xu
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Hui Zhang
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Shirui Chen
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China
| | - Jing Wu
- Department of Dermatology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, HuangGang 438000, China
| | - Liangdan Sun
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230031, China; Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, Hefei 230031, China; Anhui Province Laboratory of Inflammation and Immune Mediated Diseases 230031, China; Anhui Provincial Institute of Translational Medicine 230031, China.
| |
Collapse
|
6
|
Prospective 3-month study on the efficacy of UV-free blue light in mild psoriasis vulgaris treatment. Postepy Dermatol Alergol 2021; 38:446-449. [PMID: 34377126 PMCID: PMC8330862 DOI: 10.5114/ada.2021.107931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Accepted: 01/19/2020] [Indexed: 11/17/2022] Open
Abstract
Introduction Psoriasis is one of the most common chronic skin diseases affecting up to 2% of the general population. In recent years, an important direction for the development of treatment for psoriasis has been the use of blue light emitted by LED lamps. Aim To evaluate the efficacy of blue-light emitting device in psoriasis vulgaris treatment. Material and methods The study involved 30 adults with a mild form of psoriasis vulgaris not previously receiving biological treatment and other forms of phototherapy. Participants of the study used a device emitting blue LED light for 3 months. Each participant received a device for use at home, with which he/she exposed 2 psoriatic lesions located on the limbs. Before and after the study, the severity of the disease was evaluated using PASI, DLQI and LPSI. Results During 3 months of the therapy, a statistically significant decrease in the mean LPSI (in both treated locations) and DLQI was noted (LPSI decrease from 5.25 ±1.82 to 1.98 ±1.74, p < 0.0001; DLQI from 7.36 ±5.59 before the study to 5.23 ±4.62 after the study. Conclusions Our results confirm that phototherapy using blue LED light is both a safe and highly effective way to treat psoriasis.
Collapse
|
7
|
Barros NDM, Sbroglio LL, Buffara MDO, Baka JLCES, Pessoa ADS, Azulay-Abulafia L. Phototherapy. An Bras Dermatol 2021; 96:397-407. [PMID: 33849754 PMCID: PMC8245715 DOI: 10.1016/j.abd.2021.03.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Accepted: 03/02/2021] [Indexed: 11/29/2022] Open
Abstract
Of all the therapeutic options available in Dermatology, few of them have the history, effectiveness, and safety of phototherapy. Heliotherapy, NB-UVB, PUVA, and UVA1 are currently the most common types of phototherapy used. Although psoriasis is the most frequent indication, it is used for atopic dermatitis, vitiligo, cutaneous T-cell lymphoma, and cutaneous sclerosis, among others. Before indicating phototherapy, a complete patient assessment should be performed. Possible contraindications should be actively searched for and it is essential to assess whether the patient can come to the treatment center at least twice a week. One of the main method limitations is the difficulty that patients have to attend the sessions. This therapy usually occurs in association with other treatments: topical or systemic medications. Maintaining the regular monitoring of the patient is essential to identify and treat possible adverse effects. Phototherapy is recognized for its benefits and should be considered whenever possible.
Collapse
Affiliation(s)
- Norami de Moura Barros
- Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
| | - Lissiê Lunardi Sbroglio
- Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
| | - Maria de Oliveira Buffara
- Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
| | | | - Allen de Souza Pessoa
- Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
| | - Luna Azulay-Abulafia
- Department of Dermatology, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
| |
Collapse
|
8
|
Skarga VV, Matrosov AA, Nichugovskiy AI, Negrebetsky VV, Maslov MA, Boldyrev IA, Malakhov MV. pH-Dependent Photoinduced Interconversion of Furocoumaric and Furocoumarinic Acids. Molecules 2021; 26:2800. [PMID: 34068591 PMCID: PMC8126128 DOI: 10.3390/molecules26092800] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 05/04/2021] [Accepted: 05/07/2021] [Indexed: 12/30/2022] Open
Abstract
Photo-controlled or photo-regulated molecules, especially biologically active and operating in physiological conditions, are in steady demand. Herein, furocoumaric and furocoumarinic acids being (Z/E)-isomers relative to each other were obtained in two stages starting from psoralen: the alkaline solvolysis of psoralen led to furocoumaric acid, which was further Z → E photoisomerized (365 nm) to furocoumarinic acid. The kinetics of Z → E photoisomerization was monitored by HPLC and UV-vis spectrophotometry. Photophysical characteristics in the aqueous phase for both acids, as well as the reversibility of (Z/E) photoisomerization process, were also assessed. Furocoumarinic acid was found to be visibly fluorescent at pH 2.0-12.0, with the maxima of fluorescence emission spectra being pH-dependent. The reverse E → Z photoisomerization predicted by quantum chemistry calculations as energetically favorable for the monoanionic form of furocoumarinic acid was proved in the experiment while being complicated by pyrone ring closure back to psoralen in acidic and neutral conditions. The preparative synthesis of furocoumarinic acid outlined in this work is particularly valuable in view of a wide range of pharmacological effects previously predicted for this compound.
Collapse
Affiliation(s)
- Vladislav V. Skarga
- Institute of Translational Medicine, Pirogov Russian National Research Medical University, 1 Ostrovityanov Str., 117997 Moscow, Russia; (V.V.S.); (A.A.M.); (V.V.N.); (I.A.B.)
- Lomonosov Institute of Fine Chemical Technologies, MIREA—Russian Technological University, 86 Vernadsky Ave., 119571 Moscow, Russia; (A.I.N.); (M.A.M.)
| | - Anton A. Matrosov
- Institute of Translational Medicine, Pirogov Russian National Research Medical University, 1 Ostrovityanov Str., 117997 Moscow, Russia; (V.V.S.); (A.A.M.); (V.V.N.); (I.A.B.)
| | - Artemiy I. Nichugovskiy
- Lomonosov Institute of Fine Chemical Technologies, MIREA—Russian Technological University, 86 Vernadsky Ave., 119571 Moscow, Russia; (A.I.N.); (M.A.M.)
| | - Vadim V. Negrebetsky
- Institute of Translational Medicine, Pirogov Russian National Research Medical University, 1 Ostrovityanov Str., 117997 Moscow, Russia; (V.V.S.); (A.A.M.); (V.V.N.); (I.A.B.)
| | - Mikhail A. Maslov
- Lomonosov Institute of Fine Chemical Technologies, MIREA—Russian Technological University, 86 Vernadsky Ave., 119571 Moscow, Russia; (A.I.N.); (M.A.M.)
| | - Ivan A. Boldyrev
- Institute of Translational Medicine, Pirogov Russian National Research Medical University, 1 Ostrovityanov Str., 117997 Moscow, Russia; (V.V.S.); (A.A.M.); (V.V.N.); (I.A.B.)
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Str., 117997 Moscow, Russia
| | - Mikhail V. Malakhov
- Institute of Translational Medicine, Pirogov Russian National Research Medical University, 1 Ostrovityanov Str., 117997 Moscow, Russia; (V.V.S.); (A.A.M.); (V.V.N.); (I.A.B.)
| |
Collapse
|
9
|
Nirmal GR, Lin ZC, Tsai MJ, Yang SC, Alalaiwe A, Fang JY. Photothermal treatment by PLGA-gold nanorod-isatin nanocomplexes under near-infrared irradiation for alleviating psoriasiform hyperproliferation. J Control Release 2021; 333:487-499. [PMID: 33845057 DOI: 10.1016/j.jconrel.2021.04.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2021] [Revised: 03/28/2021] [Accepted: 04/05/2021] [Indexed: 11/17/2022]
Abstract
Psoriasis is a chronic autoimmune skin disorder that involves keratinocyte hyperproliferation and inflammatory cell recruitment. A strategy to mitigate psoriatic lesions is to induce keratinocyte apoptosis for proliferation suppression. Herein we designed a nanoformulation capable of treating psoriasis via hyperthermia-induced apoptosis in response to near-infrared (NIR) irradiation. To this end, gold nanorods (GNRs) and isatin, which is an anti-inflammatory agent for synergizing antipsoriatic activity, were loaded into a poly (lactic-co-glycolic acid) (PLGA) matrix to form the nanocomplexes. The physicochemical and photothermal properties of the nanocomplexes were determined in terms of size, surface charge, NIR-absorbing feature, isatin release, keratinocyte uptake, and cytotoxicity. The nanocomplexes showed a spherical shape with an average size of about 180 nm. The GNR-loaded nanoparticles can efficiently convert NIR light at 0.42 W/cm2 into heat with an increased temperature of 10 °C. When combined with NIR exposure, the nanocomplexes were internalized into keratinocyte cytoplasm with an inhibition of keratinocyte viability to about 60%. Live/dead cell assay and flow cytometry confirmed that the nanocomplexes could serve as NIR-absorbers to specifically elicit keratinocyte apoptosis through caspase and poly ADP-ribose polymerase (PARP) pathways. The in vivo psoriasiform murine model indicated that the combined nanocomplexes and NIR inhibited epidermal hyperplasia and neutrophil infiltration. The overexpressed cytokines in the lesion could be recovered to normal baseline level after the photothermal management. The subcutaneous nanocomplexes remained in the skin for at least 5 days. The nanocomposites produced a negligible toxicity in the skin or liver of healthy mice. The photothermal nanosystems, as designed in this study, shed new light on the therapeutic approach against psoriasis.
Collapse
Affiliation(s)
- G R Nirmal
- Graduate Institute of Biomedical Sciences, Chang Gung University, Kweishan, Taoyuan, Taiwan
| | - Zih-Chan Lin
- Graduate Institute of Biomedical Sciences, Chang Gung University, Kweishan, Taoyuan, Taiwan
| | - Ming-Jun Tsai
- Department of Neurology, China Medical University Hospital, Taichung, Taiwan; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; Department of Neurology, An-Nan Hospital, China Medical University, Tainan, Taiwan
| | - Shih-Chun Yang
- Department of Cosmetic Science, Providence University, Taichung, Taiwan
| | - Ahmed Alalaiwe
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia
| | - Jia-You Fang
- Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan, Taiwan; Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Kweishan, Taoyuan, Taiwan; Department of Anesthesiology, Chang Gung Memorial Hospital, Kweishan, Taoyuan, Taiwan.
| |
Collapse
|
10
|
Phototherapy for Psoriasis: New Research and Insights. CURRENT DERMATOLOGY REPORTS 2021. [DOI: 10.1007/s13671-020-00324-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
11
|
Skarga VV, Zadorozhny AD, Shilov BV, Nevezhin EV, Negrebetsky VV, Maslov MA, Lagunin AA, Malakhov MV. Prospective pharmacological effects of psoralen photoxidation products and their cycloadducts with aminothiols: chemoinformatic analysis. BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY 2020. [DOI: 10.24075/brsmu.2020.059] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Psoralens are medicinal photosensitizing furocoumarins which are used in photochemotherapy and photoimmunotherapy of dermatoses. Psoralen photooxidation products may be involved in therapeutic effects, but the possible mechanisms of their action remain unclear. The study was aimed to assess the prospective pharmacological effects and mechanisms of activity for six previously identified ortho–hydroxyformyl-containing psoralen photooxidation products and their cycloadducts with aminothiols, as well as for structurally similar compounds (furocoumaric acid and tucaresol). Chemoinformatic analysis of the prospective pharmacological effects and mechanisms of action of these compounds was performed using the PASS and PharmaExpert software. The predicted pharmacological effects partially confirmed by previous studies highlight the possible involvement of psoralen photooxidation products in the effects of PUVA therapy or photopheresis during the course of dermatoses and proliferative disorders treatment. A broad spectrum of pharmacological effects found for furocoumaric acid and cycloadducts of coumarinic and benzofuranic photoproducts of psoralen with cysteine and homocysteine appoints new directions of research relating to therapeutic use of psoralens.
Collapse
Affiliation(s)
- VV Skarga
- Pirogov Russian National Research Medical University, Moscow, Russia; MIREA — Russian Technological University, Moscow, Russia
| | - AD Zadorozhny
- Pirogov Russian National Research Medical University, Moscow, Russia
| | - BV Shilov
- Pirogov Russian National Research Medical University, Moscow, Russia
| | - EV Nevezhin
- Pirogov Russian National Research Medical University, Moscow, Russia
| | - VV Negrebetsky
- Pirogov Russian National Research Medical University, Moscow, Russia
| | - MA Maslov
- MIREA — Russian Technological University, Moscow, Russia
| | - AA Lagunin
- Pirogov Russian National Research Medical University, Moscow, Russia; Institute of Biomedical Chemistry (IBMC), Moscow, Russia
| | - MV Malakhov
- Pirogov Russian National Research Medical University, Moscow, Russia
| |
Collapse
|
12
|
Bruschi ML, da Silva JB, Rosseto HC. Photodynamic Therapy of Psoriasis Using Photosensitizers of Vegetable Origin. Curr Pharm Des 2020; 25:2279-2291. [PMID: 31258060 DOI: 10.2174/1381612825666190618122024] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2019] [Accepted: 06/10/2019] [Indexed: 12/16/2022]
Abstract
Psoriasis is an immune-mediated, chronic and recurrent inflammatory skin disease, prevalent worldwide, and represents an important burden in life quality of patients. The most common clinical variant is termed as psoriasis vulgaris or plaque psoriasis, which with an individualized and carefully monitored therapy can decrease the patients' morbidity and improving their life quality. The aim is to achieve disease control, minimize the adverse drug effects, and tailor the treatment to individual patient factors. Photodynamic therapy (PDT) is based on local or systemic administration of a non-toxic photosensitizer followed by irradiation with a particular wavelength to generate reactive oxygen species (ROS), mainly highly cytotoxic singlet oxygen (1O2). The generation of these species results in the attack to substrates involved in biological cycles causing necrosis and apoptosis of affected tissues. Photosensitizers are found in natural products and also obtained by partial syntheses from abundant natural starting compounds. They can be isolated at low cost and in large amounts from plants or algae. Therefore, this manuscript reviews the use of molecules from vegetal sources as photosensitizer agents for the PDT of psoriasis. Psoriasis pathogenesis, management and treatment were reviewed. PDT principles, fundamentals and utilization for the treatment of psoriasis were also discussed. Photosensitizers for PDT of psoriasis are also reviewed focusing on those from vegetal sources. Despite the PDT is utilized for the treatment of psoriasis, very little amount of photosensitizers from plant sources are utilized, such as chlorophyll derivatives and hypericin; however, other natural photosensitizers such as curcumin, could also be investigated. They could constitute a very important, safe and cheap alternative for the successful photodynamic treatment of psoriasis.
Collapse
Affiliation(s)
- Marcos L Bruschi
- Laboratory of Research and Development of Drug Delivery Systems, Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, State University of Maringa, Maringa, PR, Brazil
| | - Jéssica Bassi da Silva
- Laboratory of Research and Development of Drug Delivery Systems, Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, State University of Maringa, Maringa, PR, Brazil
| | - Hélen C Rosseto
- Laboratory of Research and Development of Drug Delivery Systems, Postgraduate Program in Pharmaceutical Sciences, Department of Pharmacy, State University of Maringa, Maringa, PR, Brazil
| |
Collapse
|
13
|
Systematic Review of the Effects of Ultraviolet Radiation on Markers of Metabolic Dysfunction. Clin Biochem Rev 2019; 40:147-162. [PMID: 31530965 DOI: 10.33176/aacb-19-00026] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Emerging findings suggest that exposure to ultraviolet wavelengths of sunlight modulates metabolic function. Here we review the metabolic effects of exposure to ultraviolet radiation (UVR), focusing on the effects of phototherapies (that administer UVR), and advice to increase sun exposure in individuals enrolled in clinical trials and intervention studies. We identified 25 studies in which the effects of UVR on metabolic outcomes were examined, including: narrowband ultraviolet B phototherapy (nbUVB, n = 12); psoralen ultraviolet A phototherapy (n = 4); other types of UVR phototherapy (n = 5); and sun exposure advice (n = 5). Most studies recruited a small number of participants (≤100), who were middle-aged individuals undergoing treatment for psoriasis flare, with phototherapy or sun exposure advice administered for ≤12 weeks. Data obtained at baseline were usually compared with an endpoint following treatment with UVR, for a limited number of outcomes. There were few studies in which markers of glucose metabolism were assessed, with some beneficial effects of sun exposure (but not phototherapy) reported. LDL-cholesterol levels were lower in individuals receiving sun exposure advice, while treatment with nbUVB reduced blood concentrations of inflammatory markers (C-reactive protein and interleukin-6). Future studies should focus on determining whether the effects of these interventions change with time, and if they are dependent on the source of UVR (i.e. phototherapy or sun exposure) and wavelength(s) of light administered. Furthermore, studies need to measure a variety of (clinical) markers of glucose metabolism, adiposity and inflammation, control for factors such as skin type and sex, and stratify participants for metabolic disease diagnosis.
Collapse
|
14
|
Guillon C, Jan YH, Heck DE, Mariano TM, Rapp RD, Jetter M, Kardos K, Whittemore M, Akyea E, Jabin I, Laskin JD, Heindel ND. Phototoxicity of 7-oxycoumarins with keratinocytes in culture. Bioorg Chem 2019; 89:103014. [PMID: 31170642 DOI: 10.1016/j.bioorg.2019.103014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2019] [Revised: 05/23/2019] [Accepted: 05/24/2019] [Indexed: 10/26/2022]
Abstract
Seventy-one 7-oxycoumarins, 66 synthesized and 5 commercially sourced, were tested for their ability to inhibit growth in murine PAM212 keratinocytes. Forty-nine compounds from the library demonstrated light-induced lethality. None was toxic in the absence of UVA light. Structure-activity correlations indicate that the ability of the compounds to inhibit cell growth was dependent not only on their physiochemical characteristics, but also on their ability to absorb UVA light. Relative lipophilicity was an important factor as was electron density in the pyrone ring. Coumarins with electron withdrawing moieties - cyano and fluoro at C3 - were considerably less active while those with bromines or iodine at that location displayed enhanced activity. Coumarins that were found to inhibit keratinocyte growth were also tested for photo-induced DNA plasmid nicking. A concentration-dependent alteration in migration on neutral gels caused by nicking was observed.
Collapse
Affiliation(s)
| | - Yi-Hua Jan
- Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, USA
| | - Diane E Heck
- Department of Environmental Science, New York Medical College, Valhalla, NY 10595, USA
| | - Thomas M Mariano
- Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, USA
| | - Robert D Rapp
- Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA
| | - Michele Jetter
- Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA
| | - Keith Kardos
- Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA
| | | | - Eric Akyea
- Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA
| | - Ivan Jabin
- Laboratoire de Chimie Organique, Université Libre de Bruxelles, B-1050 Brussels, Belgium
| | - Jeffrey D Laskin
- Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, USA
| | - Ned D Heindel
- Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA
| |
Collapse
|
15
|
Noronha-Neta MI, Picciani BLS, Niemeyer-Corbellini JP, Ramos-E-Silva M, Soares FA, Carneiro S. Quantification of histopathological changes in patients with psoriasis before and after phototherapy. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE 2019; 35:354-359. [PMID: 31166623 DOI: 10.1111/phpp.12492] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/10/2019] [Revised: 04/22/2019] [Accepted: 06/02/2019] [Indexed: 11/24/2022]
Abstract
BACKGROUND One of the most used resources for the treatment of psoriasis is ultraviolet radiation (UV) with psoralens (PUVA) and narrow-band UV (UVB-NB 311-312 nm). Although many researchers have assessed the histopathological effects of this therapy modality, none used a morphological classification system specific to psoriasis. PURPOSE To assess the clinical and histopathological response in the phototherapy treatment of plaque psoriasis with PUVA and UVB-NB with use of PASI and TROZAK. METHODS Histopathological changes of plaque psoriasis were quantified with help of the grading system for psoriasis-Trozak in 20 patients of both sexes, before and after 32 PUVA phototherapy sessions (10 patients-GPUVA) and UVB-NB (10 patients-GUVB-NB). The severity and extension of psoriasis was evaluated through PASI. The slides stained with hematoxylin and eosin were scanned in an Aperio CS2 scanner (Leica Biosystems) and evaluated through the software ImageScopeTM (Aperio Technologies). Statistical analysis was performed with the use of the program SPSS 22.0, with application of the Wilcoxon and Mann-Whitney tests. RESULTS All patients presented improvement in psoriatic plaques with decrease in PASI after treatment (P < 0.01) and significant reduction in histopathological changes in psoriasis from 15.4 ± 1.7 to 3.7 ± 3.2 (P < 0.01) in group GPUVA and from 13.2 ± 1.7 to 4.9 ± 5.2 (P < 0,01) in group GUVB-NB. CONCLUSIONS Phototherapy, regardless of type, is an effective treatment for moderate and severe psoriasis, with possibility of being quantified clinically by PASI and histopathologically by Trozak.
Collapse
Affiliation(s)
- Maria Isabel Noronha-Neta
- Sector of Dermatology - University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.,Postgraduation Program in Medical Clinics - School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - João Paulo Niemeyer-Corbellini
- Sector of Dermatology - University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Márcia Ramos-E-Silva
- Sector of Dermatology - University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.,Postgraduation Program in Medical Clinics - School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - Sueli Carneiro
- Sector of Dermatology - University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.,Postgraduation Program in Medical Clinics - School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| |
Collapse
|
16
|
Esen Salman K, Kıvanç Altunay İ, Salman A. The efficacy and safety of targeted narrowband UVB therapy: a retrospective cohort study. Turk J Med Sci 2019; 49:595-603. [PMID: 30997975 PMCID: PMC7018302 DOI: 10.3906/sag-1810-110] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Background/aim Phototherapy is a safe and effective treatment modality for numerous dermatological conditions. Recently, targeted phototherapy modalities have gained importance due to their advantages over conventional phototherapy. This retrospective study aimed to evaluate the safety and efficacy of targeted narrowband UVB phototherapy in patients with dermatological disorders. Materials and methods This single-center study included 173 patients who were treated with targeted narrowband UVB phototherapy. Demographic features, phototherapy parameters, and adverse effects were evaluated in all patients, and the treatment response was assessed in patients who attended at least one follow-up visit. Results A total of 173 patients (102 females; 71 males) with vitiligo, alopecia areata, lichen simplex chronicus, palmoplantar psoriasis, and psoriasis vulgaris were included in the study. Among 73 patients, with whom the treatment was finalized by physician, an excellent response was obtained in 10%, 52.9%, 53.8%, 28.6%, and 40% of patients with vitiligo, alopecia areata, lichen simplex chronicus, palmoplantar psoriasis, and psoriasis, respectively. The treatment was generally well tolerated and was discontinued in only two patients due to adverse effects. Conclusion This study demonstrates that targeted narrowband UVB therapy is a safe and effective treatment alternative, particularly for alopecia areata, lichen simplex chronicus, and palmoplantar and plaque-type psoriasis.
Collapse
|
17
|
Péter I, Jagicza A, Ajtay Z, Boncz I, Kiss I, Szendi K, Kustán P, Németh B. Balneotherapy in Psoriasis Rehabilitation. ACTA ACUST UNITED AC 2018; 31:1163-1168. [PMID: 29102940 DOI: 10.21873/invivo.11184] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2017] [Revised: 08/19/2017] [Accepted: 08/21/2017] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM This study aimed to report a balneotherapy-based psoriasis rehabilitation protocol and assess its effectivity. PATIENTS AND METHODS Eighty psoriatic patients who underwent a 3-week-long inward balneotherapy-based rehabilitation were enrolled. Psoriasis Area and Severity Index (PASI) score and high sensitivity C-reactive protein (CRP) were determined on admission and before discharge. RESULTS The mean PASI score and CRP level -determined on admission and before discharge-decreased significantly after the 3-week-long rehabilitation 7.15±7.3 vs. 2.62±3.05 (p<0.001) and 4.1±3.8 vs. 3.5±3.1 (p=0.026). A negative correlation was found between PASI delta and the number of spa therapies received (r=-0.228). CONCLUSION After completing the 3-week-long spa therapy based rehabilitation, both PASI score and CRP levels showed improvement of psoriasis. The complex spa therapy used during the rehabilitation is an effective tool to reduce the symptoms of psoriasis and improve the patient's well-being.
Collapse
Affiliation(s)
- Iván Péter
- Zsigmondy Vilmos SPA Hospital, Harkany, Hungary
| | | | - Zénó Ajtay
- Zsigmondy Vilmos SPA Hospital, Harkany, Hungary
| | - Imre Boncz
- Institute for Health Insurance, Faculty of Health Sciences, University of Pecs, Pecs, Hungary
| | - István Kiss
- Department of Public Health Medicine, Medical School, University of Pecs, Pecs, Hungary
| | - Katalin Szendi
- Department of Public Health Medicine, Medical School, University of Pecs, Pecs, Hungary
| | - Péter Kustán
- Department of Laboratory Medicine, Medical School, University of Pecs, Pecs, Hungary
| | - Balázs Németh
- Zsigmondy Vilmos SPA Hospital, Harkany, Hungary .,Department of Public Health Medicine, Medical School, University of Pecs, Pecs, Hungary
| |
Collapse
|
18
|
Khanna N, Nazli T, Siddiqui KM, Kalaivani M. A non-inferiority randomized controlled clinical trial comparing Unani formulation & psoralen plus ultraviolet A sol in chronic plaque psoriasis. Indian J Med Res 2018; 147:66-72. [PMID: 29749363 PMCID: PMC5967219 DOI: 10.4103/ijmr.ijmr_249_16] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Background & objectives: Though Unani medications have been used for centuries to treat psoriasis, there is paucity of published studies which have systematically evaluated their efficacy and safety. This study was conducted to establish non-inferiority of Unani medications (oral UNIM-401 and topical UNIM-403) vs psoralen plus ultraviolet A (PUVA) sol in treatment of moderate-severe chronic plaque psoriasis (CPP) in achieving psoriasis area severity index (PASI) 75 at 12 wk and to estimate proportion of patients who relapsed in follow up period of 12 weeks, after having achieved PASI 50. Methods: In this randomized, controlled trial patients with CPP were block randomized to receive either Unani treatment (147 patients) or PUVA sol (140 patients) for 12 weeks. Percentage reduction in PASI was determined in each patient at 12 wk to calculate number of patients who achieved PASI 75 as also to estimate median of percentage reduction in PASI in each group. All patients who achieved PASI 50 at 12 weeks were followed up for another 12 wk to determine proportion of patients who relapsed. Results: Of the 287 patients randomized, 84 of 147 in Unani group and 67 of 140 in PUVA sol group completed 12 weeks of treatment. On intention-to-treat (ITT) analysis, the response in patients on Unani medication was not inferior to those receiving PUVA sol, in attaining PASI 75 (16.3% in Unani group vs 15.7% in the PUVA sol group). Median of percentage reduction of PASI at 12 wk from baseline in Unani group (68.2%; −60, 100) and PUVA sol group (63%; −15.7, 100) was comparable. Proportion of patients who relapsed at 24 wk was comparable in both groups. However, frequency of clinical side effects was significantly higher (P =0.001) in PUVA sol group (16.4%) compared to Unani group (2%). Interpretation & conclusions: The findings of the present study indicated that oral UNIM-401 and topical UNIM-403 were effective and well tolerated therapeutic options in patients with moderate-severe CPP.
Collapse
Affiliation(s)
- Neena Khanna
- Department of Dermatology & Venereology, All India Institute of Medical Sciences, New Delhi, India
| | - Tamanna Nazli
- Central Council for Research in Unani Medicine, AYUSH, New Delhi, India
| | | | - Mani Kalaivani
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
| | -
- Central Council for Research in Unani Medicine, AYUSH, New Delhi, India
| |
Collapse
|
19
|
Wu JJ, Sundaram M, Cloutier M, Gauthier-Loiselle M, Guérin A, Singh R, Ganguli A. The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-α inhibitors versus phototherapy: An observational cohort study. J Am Acad Dermatol 2018; 79:60-68. [PMID: 29499292 DOI: 10.1016/j.jaad.2018.02.050] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Revised: 02/07/2018] [Accepted: 02/20/2018] [Indexed: 10/17/2022]
Abstract
BACKGROUND Psoriasis is a risk factor for cardiovascular events. OBJECTIVE To assess the risk of major cardiovascular events and the effect of cumulative treatment exposure on cardiovascular event risk in patients with psoriasis treated with tumor necrosis factor-α inhibitors (TNFis) versus phototherapy. METHODS Adult patients with psoriasis were selected from a large US administrative claims database (from the first quarter of 2000 through the third quarter of 2014) and classified in 2 mutually exclusive cohorts based on whether they were treated with TNFis or phototherapy. Cardiovascular event risk was compared between cohorts using multivariate Cox proportional hazards models. Cumulative exposure was defined based on treatment persistence. RESULTS A total of 11,410 TNFi and 12,433 phototherapy patients (psoralen plus ultraviolet A light phototherapy, n = 1117; ultraviolet B light phototherapy, n = 11,316) were included in this study. TNFi patients had a lower risk of cardiovascular events compared to phototherapy patients (adjusted hazard ratio 0.77, P < .05). The risk reduction associated with 6 months of cumulative exposure was 11.2% larger for patients treated with TNFis compared to phototherapy (P < .05). LIMITATIONS Information on psoriasis severity and mortality was limited/not available. CONCLUSIONS Patients with psoriasis who were treated with TNFis exhibited a lower cardiovascular event risk than patients treated with phototherapy. Cumulative exposure to TNFis was associated with an incremental cardiovascular risk reduction compared to phototherapy.
Collapse
Affiliation(s)
- Jashin J Wu
- Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
| | | | | | | | | | | | | |
Collapse
|
20
|
Liu HQ, Wang YM, Li WF, Li C, Jiang ZH, Bao J, Wei JF, Jin HT, Wang AP. Photobleaching characteristics of α-(8-quinolinoxy) zinc phthalocyanine, a new type of amphipathic complex. OPEN CHEM 2017. [DOI: 10.1515/chem-2017-0045] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
AbstractThe aim of this study was to reveal the photobleaching characteristics of α-(8-quinolinoxy) zinc phthalocyanine (ZnPc-F7), a new type of amphiphilic complex. Normal saline (NS), pure Roswell Park Memorial Institute (RPMI)-1640 medium (1640), RPMI-1640 medium containing 10% fetal calf serum, and cell suspension were used as solvents to study the photobleaching of ZnPc-F7 in different solutions. Absorbance and fluorescence spectra were measured. Photobleaching kinetics were observed after irradiation for 3–180 min with ZnPc-F7 concentrations of 1–40.00μg/mL. An in vivo imaging system was used to observe the distribution and photobleaching of ZnPc-F7 in mice. ZnPc-F7 was bleached both in vitro and in vivo after exposure to laser energy at 670 nm. ZnPc-F7 was not bleached without irradiation. ‘The type of solvent, irradiation time, and initial concentration influenced the photobleaching rate. Rapid initial phases followed by a slower rate of photobleaching were observed in all four solutions. Fluorescence of ZnPc-F7 in mouse skin was steady and then increased 24 h after injection. There was no significant difference in the extent of fluorescence between normal and psoriasis-like mice. Local administration of ZnPc-F7 showed higher fluorescence intensity in skin at an early time than intravenous injection and lower content in organs after 24 h.
Collapse
Affiliation(s)
- Han-Qing Liu
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100050
- Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Guangdong, China, 518036
| | - Ying-Ming Wang
- Beijing Guiqianjin Medical Technology co., Ltd, Beijing, China, 100039
| | - Wan-Fang Li
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100050
- Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd, 100050, Beijing, China
| | - Chao Li
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100050
- Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd, 100050, Beijing, China
| | - Zhi-Huan Jiang
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100050
- Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd, 100050, Beijing, China
| | - Jie Bao
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100050
- Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd, 100050, Beijing, China
| | - Jin-Feng Wei
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100050
- Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd, 100050, Beijing, China
| | - Hong-Tao Jin
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100050
- Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd, 100050, Beijing, China
| | - Ai-Ping Wang
- Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 100050
- Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd, 100050, Beijing, China
| |
Collapse
|
21
|
Influence of narrowband ultraviolet-B phototherapy on plasma concentration of matrix metalloproteinase-12 in psoriatic patients. Postepy Dermatol Alergol 2017; 34:328-333. [PMID: 28951707 PMCID: PMC5560180 DOI: 10.5114/ada.2017.69312] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2016] [Accepted: 06/01/2016] [Indexed: 02/07/2023] Open
Abstract
INTRODUCTION Matrix metalloproteinase-12 (MMP-12) may play an important role in the pathogenesis and spread of psoriatic disease. AIM To investigate plasma levels of the selected enzyme in plaque psoriasis patients before and after the course of narrowband UVB (NBUVB) therapy with respect to disease advancement. MATERIAL AND METHODS The cohort included 49 patients suffering from plaque psoriasis, divided into groups according to severity of the disease. The control group consisted of 40 healthy volunteers. Plasma levels of MMP-12 were determined using immunoenzyme assay (ELISA), while the Psoriasis Area and Severity Index (PASI) was used to define disease advancement. RESULTS The results have shown a significantly decreased plasma level of MMP-12 in the total psoriasis patient group compared to healthy individuals, declining with the increase in disease advancement. The NBUVB therapy caused a decrease in the concentration of the analyzed enzyme, but this change was not statistically significant in the total group of psoriatic patients, while a significant change was detected in patients with a mild advancement of the disease. CONCLUSIONS Decreased synthesis of MMP-12 may lead to the stimulation of the epidermal angiogenesis process, which results in the appearance and spread of psoriatic scales. Based on the obtained results, macrophage metalloelastase seems to be a negatively reacting plasma biomarker of the studied disease.
Collapse
|
22
|
Myśliwiec H, Kiluk P, Myśliwiec P, Żelazowska-Rutkowska B, Baran A, Flisiak I. Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis. Clin Exp Dermatol 2017; 42:786-790. [PMID: 28748592 DOI: 10.1111/ced.13188] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/02/2016] [Indexed: 11/30/2022]
Abstract
Psoriasis is characterized by keratinocyte resistance to apoptosis. We recently demonstrated an increase in serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients after topical treatment for psoriasis. We decided to verify whether narrowband ultraviolet B (NB-UVB) has a similar effect. Serum concentration of TWEAK was estimated in patients with exacerbated plaque psoriasis treated with NB-UVB. Baseline TWEAK levels were similar in patients with psoriasis and healthy controls, and Psoriasis Area and Severity Index (PASI) correlated inversely with TWEAK levels. Treatment with NB-UVB caused a significant reduction in PASI and concurrent increase in serum TWEAK. This finding may be due to increased expression of TWEAK receptor in psoriatic skin, which has been reported previously, with consequent binding of excess soluble TWEAK during treatment and subsequent release after treatment. Severity of plaque psoriasis and its improvement after NB-UVB treatment may be associated with TWEAK concentrations. The importance of our findings remains to be established.
Collapse
Affiliation(s)
- H Myśliwiec
- Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland
| | - P Kiluk
- Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland
| | - P Myśliwiec
- First Department of General and Endocrinological Surgery, Medical University of Bialystok, Bialystok, Poland
| | - B Żelazowska-Rutkowska
- Department of Pediatric Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland
| | - A Baran
- Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland
| | - I Flisiak
- Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland
| |
Collapse
|
23
|
Głażewska EK, Niczyporuk M, Ławicki S, Szmitkowski M, Donejko M, Zajkowska M, Będkowska GE, Przylipiak A. Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients. Ther Clin Risk Manag 2017; 13:575-582. [PMID: 28490884 PMCID: PMC5414720 DOI: 10.2147/tcrm.s125595] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Background Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are thought to be associated with the pathogenesis and spread of psoriatic disease. This study was designed to investigate the plasma levels of MMP-3, MMP-9 and TIMP-3 in plaque psoriasis patients prior to and following a course of ultraviolet B narrowband treatment with respect to disease advancement. Methods Plasma samples of 49 patients suffering from plaque psoriasis and 40 healthy volunteers were evaluated. Concentrations of MMP-3, MMP-9 and TIMP-3 were determined using enzyme-linked immunosorbent assay, while Psoriasis Area and Severity Index was used to define disease advancement. Results Plasma levels of MMP-3, MMP-9 and TIMP-3 were significantly elevated in psoriasis patients compared to healthy individuals. A course of ultraviolet B narrowband treatment resulted in a significant decline in the studied metalloproteinases. Furthermore, the concentration of selected tissue inhibitors was negatively correlated with baseline Psoriasis Area and Severity Index score. Conclusion Our research highlights the meaningful role of MMP-3, MMP-9 and TIMP-3 in psoriasis pathogenesis and clearance of disease symptoms. Furthermore, plasma levels of the analyzed metalloproteinases seem to be a valuable psoriasis biomarker.
Collapse
|
24
|
Guan J, Yuan S, Wu H, Na R, Wu X, Wang X, Bao S. Effectiveness and safety of traditional Chinese medical bath therapy combined with ultraviolet irradiation in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials. PLoS One 2017; 12:e0173276. [PMID: 28323822 PMCID: PMC5360218 DOI: 10.1371/journal.pone.0173276] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2016] [Accepted: 02/08/2017] [Indexed: 11/19/2022] Open
Abstract
Background and objective To systematically evaluate the clinical effects and safety of traditional Chinese medical bath therapy (TCMBT) combined with ultraviolet irradiation in the treatment of psoriasis. Methods Electronic database retrieval was utilized. The foreign retrieval databases consulted included those of the Cochrane Library, PubMed and EMBASE; the domestic retrieval databases included the Chinese Biomedical Literature Database (Sino-Med), the China National Knowledge Infrastructure (CNKI), VIP and the WangFang Database. Clinical randomized controlled trials were conducted to evaluate the effects of TCMBT combined with ultraviolet irradiation in the treatment of psoriasis; the language of the retrieved articles was Chinese or English. Each database was searched from its inception to August 1, 2015. Two researchers independently collected the data and analyzed the methodology of the documented literature. The researchers conducted a meta-analysis with RevMan 5.2.3 software. Results According to the available literature, 25 RCTs (randomized controlled trials) of low research quality were conducted. According to the meta-analysis, the total effective rate of TCMBT combined with ultraviolet irradiation was relatively higher than that of ultraviolet irradiation alone. The recurrence rate, incidence of adverse reactions and Psoriasis Area and Severity Index (PASI) for the combined therapy was lower than that of ultraviolet irradiation (P<0.05). Conclusion For the treatment of psoriasis, the clinical effects and safety of TCMBT combined with ultraviolet irradiation are generally better than those of ultraviolet irradiation alone. However, the original literature was written in Chinese, and the quality of the studies was not high. Thus, it is difficult to confirm the clinical effects and safety of TCMBT combined with ultraviolet irradiation. It is necessary to conduct a scientific, normalized and high-quality RCT with multiple large samples and centers.
Collapse
Affiliation(s)
- Jingzhi Guan
- Pharmaceutical Department, Inner Mongolia International Mongolian Hospital, Hohhot, Inner Mongolia, China
| | - Shaofei Yuan
- Pharmaceutical Department, The Second Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, China
| | - Hanqimuge Wu
- Pharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, Hohhot, Inner Mongolia, China
| | - Risu Na
- Department of Psychosomatic Medicine, Inner Mongolia International Mongolian Hospital, Hohhot, Inner Mongolia, China
| | - Xueqin Wu
- Pharmaceutical Department, Inner Mongolia International Mongolian Hospital, Hohhot, Inner Mongolia, China
| | - Xin Wang
- Pharmaceutical Department, Inner Mongolia International Mongolian Hospital, Hohhot, Inner Mongolia, China
| | - Shan Bao
- Pharmaceutical Department, Inner Mongolia International Mongolian Hospital, Hohhot, Inner Mongolia, China
- * E-mail:
| |
Collapse
|
25
|
Phototherapy of Psoriasis, a Chronic Inflammatory Skin Disease. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2017; 996:287-294. [PMID: 29124709 DOI: 10.1007/978-3-319-56017-5_24] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Phototherapy is an effective treatment modality for several skin diseases which has been in use from the era of the Egyptians. Insight into its mode of action has gradually accumulated over the past decades. A crucial biological effect of ultraviolet radiation is the induction of apoptosis in T lymphocytes and in keratinocytes in the epidermis. Via this mechanism inflammation-induced pathological changes characteristic of psoriasis are counteracted.Phototherapy remains the only therapeutic option for certain patient groups where modification of the systemic immune reactions is contraindicated, such as by HIV, internal malignancy or pregnancy. UVB treatment is highly cost-effective, which is important in this age of increasing health care costs.
Collapse
|
26
|
Głażewska EK, Niczyporuk M, Ławicki S, Szmitkowski M, Zajkowska M, Będkowska GE, Przylipiak A. Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients. Ther Clin Risk Manag 2016; 12:1579-1585. [PMID: 27799779 PMCID: PMC5085301 DOI: 10.2147/tcrm.s113769] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Matrix metalloproteinases (MMPs), which show a significant ability to cleave the components of extracellular matrix, and tissue inhibitors of metalloproteinases (TIMPs), which slow down the activity of those enzymes, may be implicated in the pathogenesis and spread of psoriatic disease. This study aims to analyze plasma levels of MMP-2 and TIMP-2 in plaque psoriasis patients before and after the course of narrowband ultraviolet-B (NBUVB) therapy with respect to disease advancement. PATIENTS AND METHODS A total of 49 patients suffering from plaque psoriasis and 40 healthy volunteers were enrolled into the study. Plasma levels of MMP-2 and TIMP-2 were determined using enzyme-linked immunosorbent assay, while Psoriasis Area and Severity Index (PASI) was used to define the disease advancement. RESULTS The results showed increased plasma levels of MMP-2 and TIMP-2, but this change was significant only in case of MMP-2 in total psoriatic group compared to healthy subjects. Moreover, there was an increase in the concentrations of chosen factors with an increase in the severity of the disease. The NBUVB therapy causes a decline in the concentration of the analyzed enzyme and its inhibitor, although this change was statistically significant in the total psoriatic group only in case of MMP-2. There was also a positive correlation between MMP-2, TIMP-2, and PASI score value. CONCLUSION Our study highlights a possible important role of MMP-2 in the activity of psoriasis and clearance of disease symptoms. Moreover, plasma MMP-2 seems to be a valuable psoriasis biomarker.
Collapse
|
27
|
Wang CC, Tang CH, Wang CY, Huang SY, Sue YM. Risk of skin cancer in patients on chronic haemodialysis: a nationwide, population-based study in Taiwan. Br J Dermatol 2016; 175:1175-1182. [PMID: 27273242 DOI: 10.1111/bjd.14789] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/01/2016] [Indexed: 01/08/2023]
Abstract
BACKGROUND Patients on chronic haemodialysis (HD) have a higher incidence of cancer. However, the risk of skin cancer in this population has rarely been investigated. OBJECTIVES To investigate the risk of nonmelanoma skin cancer (NMSC) and cutaneous melanoma in patients on chronic HD and to explore the associated risk factors. METHODS We performed retrospective cohort and nested case-control studies using records in the Taiwanese National Health Insurance Research Database between 1999 and 2013. The HD cohort included 79 668 incident patients on HD, for whom the standardized incidence ratios (SIRs) for incident NMSC and cutaneous melanoma were determined. In the nested case-control study, patients on HD with NMSC were matched to those without skin cancers. The impact of various factors on the development of NMSC was determined by conditional logistic regression analysis. RESULTS Among the 79 668 patients on HD, 248 cases of NMSC and 22 cases of cutaneous melanoma occurred after a mean 4·95 years of follow-up. The SIRs for NMSC and cutaneous melanoma in patients on HD were 1·58 (95% confidence interval 1·39-1·79) and 1·44 (95% confidence interval 0·91-2·19), respectively. Of the patients on HD, a higher risk of NMSC was found in men (1·5-fold), South Taiwan residents (twofold) and patients with uraemic pruritus after long-term antihistamine treatment (1·53-fold). However, the incidence of NMSC was not increased in patients with uraemic pruritus receiving ultraviolet B phototherapy. CONCLUSIONS Patients on chronic HD are at higher risk of NMSC. Uraemic pruritus further increases the risk of NMSC, which might be prevented by ultraviolet B phototherapy.
Collapse
Affiliation(s)
- C-C Wang
- Department of Dermatology, Cardinal Tien Hospital, New Taipei City, Taiwan.,School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan
| | - C-H Tang
- School of Health Care Administration, College of Management, Taipei Medical University, Taipei, Taiwan
| | - C-Y Wang
- School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.,Department of Internal Medicine and Medical Research Center, Cardinal Tien Hospital, New Taipei City, Taiwan
| | - S-Y Huang
- School of Health Care Administration, College of Management, Taipei Medical University, Taipei, Taiwan
| | - Y-M Sue
- Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.,Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
| |
Collapse
|
28
|
Nevezhin EV, Vlasova NV, Pyatnitskiy IA, Lysenko EP, Malakhov MV. On the mechanism of erythrocyte hemolysis induced by photooxidized psoralen. BIOCHEMISTRY (MOSCOW) 2016; 80:763-8. [PMID: 26531021 DOI: 10.1134/s0006297915060115] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Contemporary concepts on a possible mechanism of erythrocyte hemolysis induced by photooxidized psoralen - the medicinal photosensitizing furocoumarin - are reviewed. The hypothesis on the mechanochemical mechanism of hemolysis is considered in view of recent data on photoinduced aggregation in photooxidized psoralen solutions. Appropriate chemical structures of photoproduct hemolysins and aggregating photoproducts are discussed.
Collapse
Affiliation(s)
- E V Nevezhin
- Pirogov Russian National Research Medical University, Department of Physics and Mathematics, Moscow, 117997, Russia.
| | | | | | | | | |
Collapse
|
29
|
Abstract
Background PUVA treatment is photochemotherapy for psoriasis that combines psoralen with UVA radiation. Although PUVA is a very effective treatment option for psoriasis, there is an absence of patient resources explaining and demonstrating the process of PUVA. Studies have shown that patients who viewed videos explaining the treatment procedures for various medical conditions had a greater understanding of their treatment and were more active participants in their health. Objective To present a freely available online guide and video on PUVA treatment designed for patient education on PUVA. Methods The PUVA treatment protocol used at the University of California—San Francisco Psoriasis and Skin Treatment Center as well as available information from the literature was reviewed to design a comprehensive guide for patients receiving PUVA treatment. Results We created a printable guide and video resource that reviews the benefits and risks of PUVA, discusses the three types of PUVA (hand–foot soak, full body soak, and systemic), demonstrates the PUVA process, and provides practical tips for safe use. Conclusion Online media and video delivers material in a way that is flexible and often familiar to patients. This new format is beneficial for prospective patients planning to undergo PUVA treatment, health-care providers, and trainees who want to learn more about this treatment.
Collapse
|
30
|
Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Liao W. Erythrodermic psoriasis: pathophysiology and current treatment perspectives. PSORIASIS (AUCKLAND, N.Z.) 2016; 6:93-104. [PMID: 28856115 PMCID: PMC5572467 DOI: 10.2147/ptt.s101232] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
Erythrodermic psoriasis (EP) is a rare and severe variant of psoriasis vulgaris, with an estimated prevalence of 1%-2.25% among psoriatic patients. The condition presents with distinct histopathologic and clinical findings, which include a generalized inflammatory erythema involving at least 75% of the body surface area. The pathogenesis of EP is not well understood; however, several studies suggest that the disease is associated with a predominantly T helper 2 (Th2) phenotype. Given the morbidity and potential mortality associated with the condition, there is a need for a better understanding of its pathophysiology. The management of EP begins with a comprehensive assessment of the patient's presentation and often requires multidisciplinary supportive measures. In 2010, the medical board of the US National Psoriasis Foundation published consensus guidelines advocating the use of cyclosporine or infliximab as first-line therapy in unstable cases, with acitretin and methotrexate reserved for more stable cases. Since the time of that publication, additional information regarding the efficacy of newer agents has emerged. We review the latest data with regard to the treatment of EP, which includes biologic therapies such as ustekinumab and ixekizumab.
Collapse
Affiliation(s)
- Rasnik K Singh
- Department of Medicine, University of California – Los Angeles, David Geffen School of Medicine, Los Angeles
| | - Kristina M Lee
- Department of Dermatology, University of California – San Francisco, San Francisco
| | - Derya Ucmak
- Department of Dermatology, University of California – San Francisco, San Francisco
| | - Merrick Brodsky
- Department of Medicine, University of California – Irvine, School of Medicine, Irvine, CA
| | - Zaza Atanelov
- Department of Medicine, New York Medical College, Valhalla, NY
| | - Benjamin Farahnik
- Department of Medicine, University of Vermont College of Medicine, Burlington, VT
| | - Michael Abrouk
- Department of Medicine, University of California – Irvine, School of Medicine, Irvine, CA
| | - Mio Nakamura
- Department of Dermatology, University of California – San Francisco, San Francisco
| | - Tian Hao Zhu
- Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
| | - Wilson Liao
- Department of Dermatology, University of California – San Francisco, San Francisco
| |
Collapse
|
31
|
Abstract
Phototherapy involves repeated exposure of the skin to ultraviolet light to treat various inflammatory skin conditions such as psoriasis. Recent studies have identified specific immunologic effects of phototherapy that may underlie phototherapy efficacy. Furthermore, recent advancements have been made in developing safe and effective targeted phototherapy modalities for difficult-to-treat areas such as scalp psoriasis. Targeted phototherapy in the form of the excimer laser holds potential for more aggressive, effective treatment and long-lasting remission of psoriasis. Phototherapy is now also used successfully with biologic agents as combination therapy to treat recalcitrant psoriasis. Therefore, though one of the oldest therapeutic modalities for psoriasis, phototherapy remains a mainstay treatment with promise for further advancement.
Collapse
Affiliation(s)
- Mio Nakamura
- Department of Dermatology, University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, California, USA
| | | | - Tina Bhutani
- Department of Dermatology, University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, California, USA
| |
Collapse
|
32
|
Deni E, Zamarrón A, Bonaccorsi P, Carmen Carreño M, Juarranz Á, Puntoriero F, Sciortino MT, Ribagorda M, Barattucci A. Glucose-functionalized amino-OPEs as biocompatible photosensitizers in PDT. Eur J Med Chem 2016; 111:58-71. [PMID: 26854378 DOI: 10.1016/j.ejmech.2016.01.041] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2015] [Revised: 12/21/2015] [Accepted: 01/21/2016] [Indexed: 12/22/2022]
Abstract
Photodynamic therapy (PDT) is a minimally invasive procedure that can provide a selective eradication of neoplastic diseases by the combined effect of a photosensitizer, light and oxygen. New amino oligo(phenylene-ethynylene)s (OPEs), bearing hydrophilic glucoside terminations, have been prepared, characterized and tested as photosensitizers in PDT. The effectiveness of these compounds in combination with UVA light has been checked on two tumor cell lines (HEp-2 and HeLa cells, derived from a larynx carcinoma and a cervical carcinoma, respectively). The compounds triggered a mitotic blockage that led to the cell death, being the effect active up to 3 μm concentration. The photophysical properties of OPEs, such as high quantum yield, stability, singlet oxygen production, biocompatibility, easy cell-internalization and very good response even at low concentration, make them promising photosensitizers in the application of PDT.
Collapse
Affiliation(s)
- Elisa Deni
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali- ChiBioFarAm, Università di Messina, Messina, Italy
| | - Alicia Zamarrón
- Departamento de Biología, Universidad Autónoma de Madrid, Madrid, Spain
| | - Paola Bonaccorsi
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali- ChiBioFarAm, Università di Messina, Messina, Italy
| | - M Carmen Carreño
- Departamento de Química Orgánica, Universidad Autónoma de Madrid, Madrid, Spain
| | - Ángeles Juarranz
- Departamento de Biología, Universidad Autónoma de Madrid, Madrid, Spain
| | - Fausto Puntoriero
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali- ChiBioFarAm, Università di Messina, Messina, Italy
| | - Maria Teresa Sciortino
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali- ChiBioFarAm, Università di Messina, Messina, Italy
| | - María Ribagorda
- Departamento de Química Orgánica, Universidad Autónoma de Madrid, Madrid, Spain.
| | - Anna Barattucci
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali- ChiBioFarAm, Università di Messina, Messina, Italy.
| |
Collapse
|
33
|
Ahmad I, Rehman A, Khan JA, Rafi M, Khurshid A, Nisar H, Zaidi S, Ikram M. Effects of varying local temperature on the optical properties of cells in-vitro. Photodiagnosis Photodyn Ther 2015; 12:459-65. [DOI: 10.1016/j.pdpdt.2015.05.002] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2015] [Revised: 04/13/2015] [Accepted: 05/05/2015] [Indexed: 12/26/2022]
|
34
|
Chikin VV, Zhilova MB, Smolyannikova VA, Nefedova MA. Dynamics of expression rates of growth factor proteins in psoriatic patients receiving a phototherapy. VESTNIK DERMATOLOGII I VENEROLOGII 2015. [DOI: 10.25208/0042-4609-2015-91-3-87-95] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022] Open
Abstract
Goal. To study the dynamics of expression rates of growth factor proteins in psoriatic patients receiving the PUVA therapy. Materials and methods. The authors conducted a study of 30 patients with psoriasis vulgaris treated with the PUVA therapy. The psoriasis severity and extent of itching were assessed prior to and after the treatment by the PASI index and visual analogue scale, respectively. The expression of semaphorin 3A, amphiregulin, nerve growth factor and PGP 9.5 protein (a nerve fiber marker) in the skin was assessed by the indirect immunofluorescence method. The expression of PGP 9.5 protein was used to assess the quantity and mean length as well as average and total fluorescence intensity of nerve fibers. Results. An increased expression of amphiregulin and nerve growth factor as well as increase in the quantity, mean length and average and total fluorescence intensity of nerve fibers were revealed in the epidermis of psoriatic patients. Following a course of the PUVA therapy, a decrease in the PASI index and extent of itching, reduced expression of amphiregulin and nerve growth factor as well as reduced quantity, mean length and average and total fluorescence intensity of nerve fibers in the epidermis were observed. Direct correlation dependence between the extent of itching, amphiregulin and nerve growth factor expression level and quantity and length of nerve fibers in the epidermis was discovered. Direct correlation dependence between the amphiregulin and nerve growth factor expression level, and average length of nerve fibers in the epidermis was discovered. Conclusion. The itching intensity in psoriatic patients receiving the PUVA therapy is reduced due to the decreased skin expression of the nerve growth factor and amphiregulin.
Collapse
|